BRLIW's logo.
Ticker Symbol: BRLIW

Brilliant Acquisition Corp - Warrants (31/03/2025)

$0.44 - 14-07-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Warrant CIK:0001787518

Company Profile

genedx was founded in 2000 by two scientists from the national institutes of health (nih) to address the needs of patients and clinicians in diagnosing rare inherited disorders. currently, genedx offers testing for more than 400 rare mendelian disorders, and gene panels for inherited cardiac disorders, inherited cancer syndromes, neurological disorders, and mitochondrial disorders. in addition, genedx also offers whole exome sequencing and whole genome chromosomal microarray testing. our highly trained and experienced physicians, geneticists, and genetic counselors work as a team to bring gene discoveries to clinical medicine for use in direct patient care. for more information, please visit our website at www.genedx.com

Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: N/A
Website: N/A
CEO: N/A
Tags:
  • Finance
  • Financial Conglomerates

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: $0.00 ( -5.41%)
Days Range: $0.05 - $0.07
Beta: -
52wk. High: $0.11
52wk. Low: $0.00
Ytd. Change 174.60%
50 Day Moving Average: $0.07
200 Day Moving Average: $0.05
Shares Outstanding: 4861000

Valuation

Market Cap: 2.1B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A